JAMES REED: Open Payments
NPI 1861699498 · LONGWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 17 payments from 8 companies in 2025. Trend: 2023 $210 · 2024 $312 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $139 |
| Supernus Pharmaceuticals, Inc. | 3 | $45 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Tris Pharma Inc | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
Products named: VRAYLAR, Qelbree, REXULTI, SPRAVATO, COBENFY, Onyda XR, CAPLYTA.
Industry payments across FL — which companies pay providers there.
